NL8100292A - Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. - Google Patents
Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. Download PDFInfo
- Publication number
- NL8100292A NL8100292A NL8100292A NL8100292A NL8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A
- Authority
- NL
- Netherlands
- Prior art keywords
- amsa
- organic acid
- composition
- gluconolactone
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11480980A | 1980-01-24 | 1980-01-24 | |
US11480980 | 1980-01-24 | ||
US19435080 | 1980-10-17 | ||
US06/194,350 US4322424A (en) | 1980-01-24 | 1980-10-17 | Crystalline glucoconate salt of m-AMSA and compositions containing same |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8100292A true NL8100292A (nl) | 1981-08-17 |
Family
ID=26812557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8100292A NL8100292A (nl) | 1980-01-24 | 1981-01-21 | Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4322424A (da) |
AT (1) | AT380474B (da) |
AU (1) | AU543758B2 (da) |
CA (1) | CA1252103A (da) |
CH (1) | CH648023A5 (da) |
DE (1) | DE3102026A1 (da) |
DK (1) | DK29781A (da) |
FI (1) | FI79840C (da) |
FR (1) | FR2474493B1 (da) |
GB (1) | GB2068729B (da) |
GR (1) | GR82326B (da) |
IE (1) | IE50884B1 (da) |
IT (1) | IT1170638B (da) |
LU (1) | LU83081A1 (da) |
NL (1) | NL8100292A (da) |
SE (1) | SE453497B (da) |
YU (1) | YU42552B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU186383B (en) * | 1981-02-27 | 1985-07-29 | Biogal Gyogyszergyar | Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts |
US4575509A (en) * | 1983-01-31 | 1986-03-11 | Bristol-Myers Company | Water-soluble formulations of m-AMSA with pyroglutamic acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1674923A (en) * | 1924-04-12 | 1928-06-26 | Schnorf Carl | Process for the production of carbohydrate-acridine compounds and solutions thereof |
US3839344A (en) * | 1973-03-28 | 1974-10-01 | Schering Corp | N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid |
US4258191A (en) * | 1979-03-29 | 1981-03-24 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Multi-step process for the production of methanesulfon-m-anisidide, 4'-(9-acridinylamino)- |
AU534608B2 (en) * | 1979-09-14 | 1984-02-09 | Warner-Lambert Corporation | Compounds having antitumour properties |
ZA811304B (en) * | 1980-03-11 | 1982-06-30 | Warner Lambert Co | Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide |
-
1980
- 1980-10-17 US US06/194,350 patent/US4322424A/en not_active Expired - Lifetime
-
1981
- 1981-01-20 YU YU145/81A patent/YU42552B/xx unknown
- 1981-01-21 AU AU66512/81A patent/AU543758B2/en not_active Ceased
- 1981-01-21 NL NL8100292A patent/NL8100292A/nl not_active Application Discontinuation
- 1981-01-21 IT IT47604/81A patent/IT1170638B/it active
- 1981-01-21 SE SE8100341A patent/SE453497B/sv not_active IP Right Cessation
- 1981-01-22 DK DK29781A patent/DK29781A/da not_active Application Discontinuation
- 1981-01-22 DE DE19813102026 patent/DE3102026A1/de active Granted
- 1981-01-22 FI FI810180A patent/FI79840C/fi not_active IP Right Cessation
- 1981-01-22 CA CA000369109A patent/CA1252103A/en not_active Expired
- 1981-01-23 IE IE119/81A patent/IE50884B1/en unknown
- 1981-01-23 FR FR8101233A patent/FR2474493B1/fr not_active Expired
- 1981-01-23 LU LU83081A patent/LU83081A1/fr unknown
- 1981-01-23 GR GR63955A patent/GR82326B/el unknown
- 1981-01-23 GB GB8102175A patent/GB2068729B/en not_active Expired
- 1981-01-26 CH CH484/81A patent/CH648023A5/de not_active IP Right Cessation
- 1981-01-26 AT AT0032681A patent/AT380474B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE810119L (en) | 1981-07-24 |
LU83081A1 (fr) | 1981-09-10 |
FI810180L (fi) | 1981-07-25 |
GB2068729B (en) | 1983-10-19 |
CA1252103A (en) | 1989-04-04 |
CH648023A5 (de) | 1985-02-28 |
US4322424A (en) | 1982-03-30 |
GB2068729A (en) | 1981-08-19 |
FI79840B (fi) | 1989-11-30 |
DE3102026C2 (da) | 1990-05-31 |
IT1170638B (it) | 1987-06-03 |
IE50884B1 (en) | 1986-08-06 |
DE3102026A1 (de) | 1982-03-04 |
FR2474493B1 (fr) | 1985-12-13 |
YU14581A (en) | 1983-06-30 |
FR2474493A1 (fr) | 1981-07-31 |
IT8147604A1 (it) | 1982-07-21 |
YU42552B (en) | 1988-10-31 |
SE8100341L (sv) | 1981-07-25 |
AU543758B2 (en) | 1985-05-02 |
IT8147604A0 (it) | 1981-01-21 |
DK29781A (da) | 1981-07-25 |
AU6651281A (en) | 1981-07-30 |
FI79840C (fi) | 1990-03-12 |
ATA32681A (de) | 1985-10-15 |
SE453497B (sv) | 1988-02-08 |
AT380474B (de) | 1986-05-26 |
GR82326B (da) | 1984-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100744917B1 (ko) | 신규한 결정형의N-[4-[2-(2-아미노-4,7-디히드로-4-옥소-3H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일]-L-글루탐산 및 이의 제조방법 | |
JP6942182B2 (ja) | カルグルミン酸を含有する非経口的薬剤配合物 | |
US20160143911A1 (en) | Stable and water soluble pharmaceutical compositions comprising pemetrexed | |
EP3008064B1 (en) | Stable pemetrexed arginine salt and compositions comprising it | |
US4360523A (en) | Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide | |
CN108350457B (zh) | 稳定地含有抑制TGF-β1基因的表达的单链核酸分子的组合物 | |
NL8100292A (nl) | Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. | |
JPH10502616A (ja) | Dx−52−1化合物の安定化法及びその凍結乾燥組成物 | |
EP1740214B1 (en) | Method of stabilizing disordered cefovecin sodium salt | |
JPH0343251B2 (da) | ||
CA1159368A (en) | Antitumor compositions | |
US4425348A (en) | Antitumor compositions | |
US4575509A (en) | Water-soluble formulations of m-AMSA with pyroglutamic acid | |
WO2001076603A1 (fr) | Compositions medicamenteuses contenant un derive de camptothecine et un agent de regulation de ph | |
NL8803126A (nl) | Waterige preparaten die een piperidinylcyclopentylhepteenzuurderivaat bevatten. | |
JPH032862B2 (da) | ||
NL8006440A (nl) | Verbindingen en preparaten met anti-tumorwerking; werkwijze voor het bereiden daarvan. | |
KR810002136B1 (ko) | 아목시실린 나트륨 함유 주사용 약제조성물의 제조방법 | |
JPS6348877B2 (da) | ||
WIRKSTOFFEN et al. | TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME | |
WO2006032386A1 (de) | Lyophilisat enthaltend n-diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BRISTOL-MYERS SQUIBB COMPANY |
|
BV | The patent application has lapsed |